Paragon 28 to Present at Upcoming Investor Conferences

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. GNK

6. USO
7. AWK
8. ARGX
9. AZN
10. SPCX

Get Alerts FNA Hot Sheet

Price: $13.09 --0%

Overall Analyst Rating:
SELL (= Flat)

Join SI Premium – FREE

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will be presenting in fireside chats at two upcoming investor conferences. Paragon 28 will participate in the CG 2023 Musculoskeletal Conference on March 7th, 2023, and the 22nd Annual Needham Virtual Healthcare Conference on April 19th, 2023.

Event: CG 2023 Musculoskeletal Conference
Date: Tuesday, March 7, 2023
Time: 4:00pm ET / 1:00pm PT

Event: 22nd Annual Needham Virtual Healthcare Conference
Date: Wednesday, April 19, 2023
Time: 11:00am ET / 8:00am PT

Live and archived webcasts of the fireside chats will be available on the “Investors” section of the Company’s website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.